Newsroom

   
Lupin Receives Tentative Approval for Generic Livalo® Tablets
December 30, 2016
Lupin Receives Tentative Approval for Generic Giazo® Tablets
December 29, 2016
Lupin Receives Tentative Approval for Generic Benicar® Tablets
December 26, 2016
Lupin Launches Generic Vfend® Tablets and Vfend® Oral Suspension in the US
December 19, 2016
Lupin Receives FDA Approval for Generic Topicort® Ointment, 0.05%
December 14, 2016
Lupin Receives FDA Approval for Generic Topicort® Ointment
December 06, 2016
Lupin Receives Tentative Approval for Generic Zorvolex® Capsules
December 06, 2016
Lupin Receives FDA Approval for Generic Norco® Tablets
December 06, 2016
Lupin Receives FDA Approval for Generic Nuvigil® Tablets
November 29, 2016
Lupin Receives Tentative Approval for Generic Epzicom® Tablets
November 23, 2016
Lupin Launches Generic Activella® Tablets in the US
November 15, 2016
Lupin Receives FDA Approval for Generic Ortho-Cyclen® 28 Tablets
November 01, 2016
Lupin and Monosol Rx announce licensing agreement for multiple pediatric-focused products
October 06, 2016
Lupin Receives FDA Approval for Generic Namenda XR® Capsules
September 29, 2016
Lupin Receives FDA Approval for Potassium Chloride Extended-Release Capsules
August 17, 2016
Lupin Receives FDA Approval for Generic Klor-Con® Extended-Release Tablets
August 10, 2016
Lupin Receives Tentative Approval for Generic Lexiva® Tablets, 700 mg from US FDA
July 27, 2016
Lupin Launches Generic Ortho Tri-Cyclen® Tablets in the US
July 20, 2016
Lupin Receives FDA Approval for Generic Activella® Tablets
June 22, 2016
Lupin Receives FDA Approvals for Generic Vfend® Tablets 50mg, 200mg & Vfend® Oral Suspension, 40 mg/mL
June 06, 2016
Lupin Bolsters US Brands Portfolio with Methergine® Oral Tablets
April 28, 2016
Lupin Launches Generic Femhrt® Tablets in the US
April 18, 2016
Lupin Launches Generic Intermezzo® Sublingual Tablets in the US
April 05, 2016
Lupin Launches Generic Aricept® Tablets in the US
March 31, 2016
Lupin Completes its Acquisition of GAVIS in the Us
March 9, 2016
Lupin Launches Generic Glumetza® HCI ER Tablets in the US
February 2, 2016
Lupin Receives FDA Approval for Generic Generess® Tablets
January 08, 2016
Lupin Launches Generic Ortho Tri-Cyclen® Lo Tablets
January 06, 2016
Lupin Receives FDA Approval for Generic Femhrt® Tablets
December 28, 2015
Lupin Receives FDA Approval for Potassium Chloride Extended Release Capsules
December 23, 2015
Lupin Receives FDA Approval for Generic Loestrin®24 Fe Tablets
November 03, 2015
Lupin receives FDA Approval for Generic Aricept® Tablets
November 03, 2015
Lupin Launches Generic PhosLo® in the US
October 26, 2015
Lupin and Boehringer Ingelheim Announce Strategic Co-marketing Agreement
October 14, 2015
Lupin launches first ever Duloxetine 40mg Delayed-Release Capsules in the US
September 03, 2015
Lupin Announces New Center of Excellence for Inhalation Research in Florida
August 7, 2015
Lupin Acquires Specialty Product Portfolio in Germany
July 24, 2015
Lupin Acquires GAVIS to Expand US Generic Business
July 23, 2015
Lupin Acquires Biocom in Russia
July 02, 2015
Lupin Acquires Medquimica in Brazil
May 13, 2015
Lupin Launches Generic Exforge® Tablets in the US
April 01, 2015
LUPIN COMPLETES ACQUISTION OF PHARMA DYNAMICS, SOUTH AFRICA
March 16, 2015
Lupin Receives US FDA Approval for Generic Lumigan® Ophthalmic Solution 0.03%.
February 23, 2015
Lupin PR - Lupin Launches InspiraChamber Anti-Static Valved Holding Chamber Expands US Brands Portfolio
February 18, 2015
Lupin and Celon Announce Strategic Development and Licensing Agreement for Generic Advair Diskus®
February 17, 2015
Lupin Receives FDA Approval for Generic Vancocin® Capsules
February 02, 2015
Lupin launches Generic DIOVAN® Tablets
January 06, 2015
   
Lupin Receives FDA Approval for Generic Epivir® Tablets
December 26, 2014
   
Lupin Launches Authorized Generic for Celebrex® Capsules
December 11, 2014
   
Lupin Receives FDA Approval for Generic Celebrex® Capsules
November 03, 2014
   
Lupin Announces Strategic Alliance for Emerging Markets
September 16, 2014
   
Lupin and Salix Announce Exclusive Distribution Agreement for Canada,Zaxine®, Relistor® and Other Gastroenterology Products
September 12, 2014
   
Lupin Launches Generic Cipro® for Oral Suspension in the US
June 18, 2014
   
Lupin Inks Strategic Joint Venture Agreement with Yoshindo Inc..
April 23, 2014
   
Lupin Appoints Theresa Stevens as Chief Corporate Development Officer.
April 21, 2014
   
Lupin Receives FDA Approval for Generic Actos® Tablets.
April 9, 2014
   
Lupin Acquires Laboratorios Grin S.A. De C.V., Mexico.
March 27, 2014
   
Lupin launches Generic Niaspan® Tablets in the US.
March 21, 2014
   
Lupin Receives FDA Approval for Generic Monodox® Capsules and Cipro® for Oral Suspension.
March 06, 2014
   
Lupin Receives FDA Approval for Generic Mycobutin® Capsules.
Feb 26, 2014
   
Lupin Appoints Dr. Maurice Chagnaud as President-Europe & Head of Inhalation Strategy
Feb 18, 2014
   
Lupin Acquires Nanomi B.V. Enters Complex Injectables Space
Feb 3, 2014
   
Strong Growth, Record Profits Quarter III Results, FY 2013-14 Net Sales up 21%, EBITDA up 28%, Net profit up 42% Declares Interim Dividend of 150%
Feb 3, 2014
   
Lupin launches Generic Trizivir® Tablets
Dec 18, 2013
   
Lupin launches Generic Cymbalta® Delayed-Release Capsules 20 mg, 30 mg and 60 mg strengths in the US
Dec 12, 2013
   
Lupin Receives FDA Approval for Generic Trizivir® Tablets
Dec 10, 2013
   
Lupin launches Generic Trilipix® Delayed - Release Capsules 45 mg & 135 mg in the US
Dec 06, 2013
   
Lupin launches Generic Aciphex® Delayed-Release Tablets, 20 mg in the US
Nov 11, 2013
   
Lupin Receives FDA Approval for its New Drug Application for Antara® Capsules
Oct 22, 2013
   
Lupin launches Generic ZYMAXID™ Ophthalmic solution in the US
Oct 3, 2013
   
Lupin Receives FDA Approval for Generic Ambien CR® Extended-release Tablets
Sept 16, 2013
   
Lupin receives FDA Approval for Generic Ranexa® Extended-release Tablets
Aug 1, 2013
   
Lupin Receives Tentative FDA Approvals for Generic Nuvigil® Tablets and Generic Oracea® Capsules
Jul 31, 2013
   
Lupin receives FDA approval for its Oral Contraceptive Pirmella™ 7/7/7 and Pirmella™ 1/35 Tablets
Apl 26, 2013
   
Lupin announces favorable ruling for generic Yaz® Oral Contraceptive Tablets
Apl 17, 2013
   
Lupin launches its Oral Contraceptive DayseeTM Tablets in the US Market Generic of Seasonique® Tablets
Apl 12, 2013
   
Lupin Launches Generic Diovan HCT® Tablets
Mar 22, 2013
   
Lupin to launch Generic Yasmin® Tablets; receives FDA approval
Dec 19, 2012
   
Lupin launches Generic TRICOR® Tablets
Nov 20, 2012
   
Lupin Launches Fenofibrate Tablets, AB rated to Tricor®
Nov 20, 2012
   
Lupin launches Generic Seasonale® Tablets; receives FDA approval
Oct 25, 2012
   
Lupin receives FDA approval for its Oral Contraceptive Kurvelo® Tablets; The Generic of Nordette® Tablets
Oct 18, 2012
   
Lupin receives FDA approval for Generic Lexapro® Tablets
July 03, 2012
   
Lupin receives FDA approval for Generic Ortho Tri-cyclen Lo ® Tablets
July 03, 2012
Lupin Launches Generic Combivir® Tablets
May 15, 2012
Lupin Resumes Sales of Generic Fortamet®
April 19, 2012
Lupin launches Generic SEROQUEL® Tablets Receives final FDA Approval for its Generic SEROQUEL® Tablets
March 28, 2012
Lupin launches Generic Geodon® Capsules Receives final FDA Approval for its Generic Geodon® Capsules
March 03, 2012
Lupin Announces U.S. FDA Approval of its First Oral Contraceptive
Sept 16, 2011
Lupin Announces Launch of Generic KEPPRA XR® Tablets
Sept 12, 2011
Lupin Announces Launch of Generic Version of Ponstel® Capsules
Sept 06, 2011
Lupin Receives Final Approval to Market Generic Ultram® ER
Aug 29, 2011
Lupin Launches Additional Strengths of Generic Lotrel® Capsules
July 06, 2011
Lupin Announces Launch of Generic Levaquin® Tablets for the US Market
Jun 22, 2011
HDMA Honors Lupin with DIANA Award for Best Overall Generic Manufacturer
Jun 08, 2011
Lupin Announces Final FDA Approval of Generic Hyzaar® and Cozaar®
Oct 06, 2010
Lupin receives FDA approval for Famotidine for Oral Suspension
Jun 29, 2010
Lupin receives FDA approval for Imipramine Pamoate Capsules
Apr 16, 2010
Lupin receives FDA tentative approval for Eszopiclone tablets
Mar 20, 2010
Lupin receives FDA approval for Amlodipine/Benazepril capsules
Feb 08, 2010
Lupin receives FDA approval for Perindopril Erbumine Tablets
Jan 28, 2010
Lupin receives FDA tentative approval for Memantine HCl tablets
Jan 19, 2010
Lupin is granted USFDA approval for Levetiracetam Tablets
Jan 16, 2009

Copyright © 2010, Lupin Pharmaceuticals, Inc., All Rights Reserved.